# MarketWise share price today (MarketWise, Inc., MKTW)

> MarketWise, Inc.'s balance sheet is under water: its net worth is negative, so it owes more than it owns. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. MKTW · Financials · Financial Data & Stock Exchanges · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/mktw

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from fewer quarters than usual
- Price: $20.85 (+22.8% in a year)
- Revenue (Jun 2026): $75.8 M (−5.2% on a year ago)
- Profit (Jun 2026): −$629 K (−148.5% on a year ago)
- Net margin: −0.8% (−2.4 points on a year ago)
- ROA: 8.50%, latest

The main question: the share price moved +22.8% in a year while yearly earnings per share moved −35.5%. The difference came from the market paying a higher multiple. ## What is the MarketWise share price today? MarketWise, Inc.'s share price was $20.85 at the close on 3 November 2026. That is 17.7% above its average price over the last 200 trading days. In the last 52 weeks it traded between $14 and $21, and at that close it was at the high of that range. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row. Over the last 1 year the share price moved +17% while the S&P 500 moved +21%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does MarketWise pay? MarketWise, Inc. paid $0.90 per share over the last four reported quarters. The most recent declaration was $0.25 for Jun 2026. At today's price of $20.85 that is a yield of 4.32%, based on dividends already paid, not a forecast. ## Which stock lists is MarketWise on? MarketWise is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is MarketWise profitable? MarketWise, Inc. posted a net loss of $629 K in the Jun 2026 quarter. Full-year FY25 profit was $5.6 M. Over 4 years profit has grown −25.5% a year on average. That loss is 0.8% of the quarter's revenue. The same quarter a year earlier earned $1.3 M. 2 of the last 12 reported quarters were loss-making. Jun 2026 profit was −$629 K, −148.5% on a year earlier. For the full year, FY25 profit was $5.6 M (−20.4% on the year before). Why profit moved: revenue changed −5.2% on a year earlier and the margin moved −2.4 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −83.8% and revenue −10.9%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does MarketWise make, and is it growing? MarketWise, Inc. reported $75.8 M of income in the Jun 2026 quarter, −5.2% on the same quarter a year earlier. Over 4 years it has grown −12.1% a year on average. The last full year, FY25, came in at $328 M. The last four reported quarters add to $318 M. FY25 revenue was $328 M, −19.7% on the year before. Recent pace: the last four quarters grew −10.9% on average, against −12.1% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −11.3%, against −14.3% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −63.1%, against −19.9% a year (rolling over). ## How much does MarketWise keep from what it earns? MarketWise, Inc.'s net margin was −0.8% in the Jun 2026 quarter, 2.4 percentage points lower than the same quarter a year ago. Across 5 years it has been between 0.4% and 3.5%. The latest quarter is below every full year in that period. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## How many of MarketWise's loans have gone bad? MarketWise, Inc. does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is MarketWise's loan book growing? MarketWise, Inc.'s revenue was $328 M in FY25, −19.7% on the year before, so the loan book is not growing. The latest quarter was −5.2% on a year earlier. The net margin on that income is −0.8%, −2.4 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch. ## What is MarketWise's P/BV ratio, and how does it compare with its own history? MarketWise, Inc. has no P/BV right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values MarketWise, Inc. at 1.0× its FY25 revenue of $328 M. The P/BV comes back here once profit turns positive. Why the multiple is where it is: over the past year book value grew while the price moved +22.8%. Price and book value moved together, so the multiple stayed in its range. ## Is the MarketWise business getting better or worse? MarketWise, Inc.'s business is getting worse. Revenue, profit and EPS growth are shrinking: revenue growth is −11.3% in the latest quarter, against −8.7% at its best in 12 quarters, with ROE rising at -2.6%. This is based on 12 quarters of 4 measures, with some gaps. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does MarketWise earn on its equity and assets? MarketWise, Inc. earned a return on equity of −3% in FY25. Its lowest yearly reading on file was −6% in FY22. On its assets, every $100 earned about $8.50, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together. That return is below the level a bank needs to grow its net worth quickly, which helps explain why its multiple is where it is. Why ROE moved: profit grew −25.5% a year over 4 years while net worth grew more slowly. When earnings recover faster than net worth builds up, ROE climbs off its low. ## Does MarketWise have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the MarketWise shareholding pattern? 4.5% of MarketWise, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.4 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is MarketWise from balance-sheet trouble? For MarketWise, Inc., the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does MarketWise rank in its industry? 36.9 out of 100, rank 12 of 14 in Financial Data & Stock Exchanges, with 54% of the evidence available. MarketWise, Inc. scores 36.9 out of 100 against the 14 companies it is compared with in Financial Data & Stock Exchanges, ranking 12. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 7.2 + 8 + 9.8 + 11.9 = 36.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is MarketWise compared with? MarketWise ranks 12 of 14 Financial Data & Stock Exchanges companies on the 4-Factor Sector Score, with 36.9 out of 100. 1. [Cboe Global Markets, Inc.](https://www.sectoralpha.in/us/stocks/cboe) CBOE · breaking out · Most evidence points up · 76% evidence 69.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.3/35 · Income 11.7% · Profit 50.3% · 71% evidence Capital efficiency 18.3/25 · ROA 12.4% · ROE 29.4% · GNPA n/a · 68% evidence Valuation 11.2/20 · P/BV 4.51× · P/BV÷ROE 0.15 · 70% evidence Relative strength 14.8/20 · Lead over its industry 5.3% · Lead over S&P 500 14% · 1 year 34.2% · 100% evidence · 7 of 12 weeks ahead Exact sum: 25.3 + 18.3 + 11.2 + 14.8 = 69.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Morningstar, Inc.](https://www.sectoralpha.in/us/stocks/morn) MORN · breaking out · Most evidence points up · 76% evidence 68.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.5/35 · Income 9.3% · Profit 4.2% · 71% evidence Capital efficiency 17.9/25 · ROA 10.3% · ROE 38.2% · GNPA n/a · 68% evidence Valuation 11.5/20 · P/BV 5.79× · P/BV÷ROE 0.15 · 70% evidence Relative strength 19.3/20 · Lead over its industry 9% · Lead over S&P 500 17.4% · 1 year 9.8% · 100% evidence · 12 of 12 weeks ahead Exact sum: 19.5 + 17.9 + 11.5 + 19.3 = 68.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Intercontinental Exchange, Inc.](https://www.sectoralpha.in/us/stocks/ice) ICE · breaking out · Evidence leans up · 76% evidence 62.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.6/35 · Income 9% · Profit 34.5% · 71% evidence Capital efficiency 15.0/25 · ROA 2.7% · ROE 19.6% · GNPA n/a · 68% evidence Valuation 14.6/20 · P/BV 2.35× · P/BV÷ROE 0.12 · 70% evidence Relative strength 10.2/20 · Lead over its industry -3.5% · Lead over S&P 500 4.1% · 1 year 14.7% · 100% evidence · 11 of 12 weeks ahead Exact sum: 22.6 + 15 + 14.6 + 10.2 = 62.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Moody's Corporation](https://www.sectoralpha.in/us/stocks/mco) MCO · turning · Evidence leans up · 80% evidence 58.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.9/35 · Income 9% · Profit 28.5% · 81% evidence Capital efficiency 20.3/25 · ROA 18.4% · ROE 111.5% · GNPA n/a · 68% evidence Valuation 7.9/20 · P/BV 23.05× · P/BV÷ROE 0.21 · 70% evidence Relative strength 4.5/20 · Lead over its industry -6.4% · Lead over S&P 500 1.2% · 1 year 3.2% · 100% evidence · 3 of 12 weeks ahead Exact sum: 25.9 + 20.3 + 7.9 + 4.5 = 58.6 · What this means: Earnings are strong; relative strength in its sector is -6.4% and the one-year return is 3.2%. 5. [TransUnion](https://www.sectoralpha.in/us/stocks/tru) TRU · turning · Evidence leans up · 76% evidence 58.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Income 12.4% · Profit 84.3% · 71% evidence Capital efficiency 16.5/25 · ROA 5.3% · ROE 33.9% · GNPA n/a · 68% evidence Valuation 16.3/20 · P/BV 2.78× · P/BV÷ROE 0.08 · 70% evidence Relative strength 2.2/20 · Lead over its industry -9.3% · Lead over S&P 500 -2.1% · 1 year -2.5% · 100% evidence · 5 of 12 weeks ahead Exact sum: 23.4 + 16.5 + 16.3 + 2.2 = 58.4 · What this means: Earnings are strong; relative strength in its sector is -9.3% and the one-year return is -2.5%. 6. [Nasdaq, Inc.](https://www.sectoralpha.in/us/stocks/ndaq) NDAQ · turning · Evidence leans up · 80% evidence 58.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.7/35 · Income 13.7% · Profit 28.3% · 81% evidence Capital efficiency 15.8/25 · ROA 6.8% · ROE 16.9% · GNPA n/a · 68% evidence Valuation 5.0/20 · P/BV 4.29× · P/BV÷ROE 0.25 · 70% evidence Relative strength 11.7/20 · Lead over its industry 3.1% · Lead over S&P 500 11.4% · 1 year 22.6% · 100% evidence · 8 of 12 weeks ahead Exact sum: 25.7 + 15.8 + 5 + 11.7 = 58.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [MSCI Inc.](https://www.sectoralpha.in/us/stocks/msci) MSCI · turning · Evidence leans up · 64% evidence 55.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.5/35 · Income 12.3% · Profit 13.1% · 71% evidence Capital efficiency 14.5/25 · ROA 21.9% · ROE -51% · GNPA n/a · 68% evidence Valuation 9.8/20 · P/BV -12.98× · P/BV÷ROE n/a · 10% evidence Relative strength 10.1/20 · Lead over its industry -1.8% · Lead over S&P 500 6.2% · 1 year 9.8% · 100% evidence · 3 of 12 weeks ahead Exact sum: 21.5 + 14.5 + 9.8 + 10.1 = 55.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [S&P Global Inc.](https://www.sectoralpha.in/us/stocks/spgi) SPGI · turning · Evidence leans up · 76% evidence 55.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/35 · Income 9.7% · Profit 22.6% · 71% evidence Capital efficiency 15.8/25 · ROA 7.6% · ROE 16.6% · GNPA n/a · 68% evidence Valuation 9.6/20 · P/BV 3.29× · P/BV÷ROE 0.2 · 70% evidence Relative strength 7.8/20 · Lead over its industry -8% · Lead over S&P 500 -0.9% · 1 year -6.1% · 100% evidence · 2 of 12 weeks ahead Exact sum: 21.9 + 15.8 + 9.6 + 7.8 = 55.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [FactSet Research Systems Inc.](https://www.sectoralpha.in/us/stocks/fds) FDS · leader · Evidence leans up · 80% evidence 53.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.7/35 · Income 6.6% · Profit -10.7% · 81% evidence Capital efficiency 18.1/25 · ROA 11.3% · ROE 24.4% · GNPA n/a · 68% evidence Valuation 6.0/20 · P/BV 5.57× · P/BV÷ROE 0.23 · 70% evidence Relative strength 19.7/20 · Lead over its industry 13.6% · Lead over S&P 500 22.6% · 1 year 26.7% · 100% evidence · 10 of 12 weeks ahead Exact sum: 9.7 + 18.1 + 6 + 19.7 = 53.5 · What this means: Relative strength against the index is 22.6%, and revenue and profit growth are weak. 10. [CME Group Inc.](https://www.sectoralpha.in/us/stocks/cme) CME · breaking out · Evidence leans down · 80% evidence 43.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.3/35 · Income 8.9% · Profit 18.5% · 81% evidence Capital efficiency 12.7/25 · ROA 1.4% · ROE 15.7% · GNPA n/a · 68% evidence Valuation 7.0/20 · P/BV 3.55× · P/BV÷ROE 0.23 · 70% evidence Relative strength 8.3/20 · Lead over its industry -4.5% · Lead over S&P 500 3.1% · 1 year 10% · 100% evidence · 8 of 12 weeks ahead Exact sum: 15.3 + 12.7 + 7 + 8.3 = 43.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Value Line, Inc.](https://www.sectoralpha.in/us/stocks/valu) VALU · breaking out · Evidence leans down · 80% evidence 42.9 out of 100 Growth Capital Valuation Relative
12. MarketWise, Inc. this page MKTW · turning · Too little evidence to rank firmly · 54% evidence 36.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 7.2/35 · Income -11.4% · Profit -66.7% · 62% evidence Capital efficiency 8.0/25 · ROA -1.4% · ROE n/a · GNPA n/a · 42% evidence Valuation 9.8/20 · P/BV -0.18× · P/BV÷ROE n/a · 10% evidence Relative strength 11.9/20 · Lead over its industry 5.4% · Lead over S&P 500 14.3% · 1 year 21.9% · 100% evidence · 5 of 12 weeks ahead Exact sum: 7.2 + 8 + 9.8 + 11.9 = 36.9 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 13. [Coinbase Global, Inc.](https://www.sectoralpha.in/us/stocks/coin) COIN · quiet · Most evidence points down · 64% evidence 24.8 out of 100 Growth Capital Valuation Relative
14. [Securitize Corp.](https://www.sectoralpha.in/us/stocks/secz) SECZ · losing its lead · Too little evidence to rank firmly · 47% evidence 33.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Financial Data & Stock Exchanges](https://www.sectoralpha.in/us/sectors/financial-data-stock-exchanges), all 14 compared on one page. ## Which companies are close to MarketWise in size? MarketWise is the 14th largest of 14 Financial Data & Stock Exchanges companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Cboe Global Markets, Inc., TransUnion, FactSet Research Systems Inc., Morningstar, Inc., Securitize Corp. and Value Line, Inc. It is the smallest. ### Financial Data & Stock Exchanges companies close in size

1. [Cboe Global Markets, Inc.](https://www.sectoralpha.in/us/stocks/cboe) $35.9 billion
2. [TransUnion](https://www.sectoralpha.in/us/stocks/tru) $15 billion
3. [FactSet Research Systems Inc.](https://www.sectoralpha.in/us/stocks/fds) $11.7 billion
4. [Morningstar, Inc.](https://www.sectoralpha.in/us/stocks/morn) $8.8 billion
5. [Securitize Corp.](https://www.sectoralpha.in/us/stocks/secz) $1.3 billion
6. [Value Line, Inc.](https://www.sectoralpha.in/us/stocks/valu) $434 million
7. MarketWise, Inc. $329 million

[All 14 Financial Data & Stock Exchanges companies, largest first](https://www.sectoralpha.in/us/sectors/financial-data-stock-exchanges#all-companies)

### Companies close in size in other industries

1. [BRC Inc.](https://www.sectoralpha.in/us/stocks/brcc) $315 million · Packaged Foods
2. [Alpine Income Property Trust, Inc.](https://www.sectoralpha.in/us/stocks/pine) $314 million · REIT - Retail
3. MarketWise, Inc. $314 million
4. [Arcturus Therapeutics Holdings Inc.](https://www.sectoralpha.in/us/stocks/arct) $314 million · Biotechnology
5. [vTv Therapeutics Inc.](https://www.sectoralpha.in/us/stocks/vtvt) $313 million · Biotechnology

## What else do people ask about MarketWise? ### What were MarketWise's latest quarterly results? MarketWise, Inc. reported total income of $75.8 M and a net loss of $629 K for the Jun 2026 quarter. Income fell 5.2% and profit fell 148.5% compared with a year earlier. Earnings per share were −$0.24. The net margin was −0.8%, 2.4 percentage points lower than a year earlier (as of 3 November 2026). ### What is MarketWise's market cap? MarketWise, Inc.'s market capitalisation is $329 M at a stock price of $20.85. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is MarketWise performing? MarketWise, Inc.'s latest readings are below. In its latest quarter, income fell 5.2% and profit fell 148.5% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 1 week running. This describes what the data did, not a rating (as of 3 November 2026). ### Will MarketWise's stock price go up? This page does not forecast MarketWise, Inc.'s stock price. What it shows instead: the stock price is $20.85. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is MarketWise in its business cycle? MarketWise, Inc.'s FY25 net margin was 1.7%, against a 5-year range of 0.4% to 3.5%: the middle of its own range, neither a peak nor a low. The latest quarter was −0.8%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the MarketWise story? The main question: the share price moved +22.8% in a year while yearly earnings per share moved −35.5%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is MarketWise a stock worth studying right now? What the numbers show: MarketWise, Inc.'s balance sheet is under water: its net worth is negative, so it owes more than it owns. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. The main open question: whether the business can earn its way back to positive net worth before new shares or a restructuring get there first. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.